TH104259B - Spyrochetals with fused rings and their use As an antidiabetic drug - Google Patents
Spyrochetals with fused rings and their use As an antidiabetic drugInfo
- Publication number
- TH104259B TH104259B TH701003385A TH0701003385A TH104259B TH 104259 B TH104259 B TH 104259B TH 701003385 A TH701003385 A TH 701003385A TH 0701003385 A TH0701003385 A TH 0701003385A TH 104259 B TH104259 B TH 104259B
- Authority
- TH
- Thailand
- Prior art keywords
- chemical formula
- formula
- group
- spyrochetals
- compounds
- Prior art date
Links
- 239000003472 antidiabetic agent Substances 0.000 title 1
- 239000000126 substance Substances 0.000 claims abstract 8
- 150000001875 compounds Chemical class 0.000 claims abstract 7
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims abstract 3
- 125000003710 aryl alkyl group Chemical group 0.000 claims abstract 2
- 125000004435 hydrogen atoms Chemical group [H]* 0.000 claims abstract 2
- 125000003118 aryl group Chemical group 0.000 claims 1
- 150000003839 salts Chemical class 0.000 abstract 2
- 239000011780 sodium chloride Substances 0.000 abstract 2
- 239000000470 constituent Substances 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000000529 probiotic Effects 0.000 abstract 1
- 239000006041 probiotic Substances 0.000 abstract 1
- 235000018291 probiotics Nutrition 0.000 abstract 1
Abstract
ที่จัดเตรียมเป็นสารประกอบซึ่งแทนโดยสูตร (I) [สูตร 1] (สูตรเคมี (I) ที่ซึ่ง R1,R2,R3 , และ R4 อย่างไม่ขึ้นแก่กัน แต่ละหมู่ได้รับการคัดเลือกจากอะตอมของ ไฮโดรเจน, หมู่ C1-6 แอลคิลซึ่งอาจได้รับการแทนที่, หมู่ C7-14 อะแรลคิลซึ่งอาจได้รับการแทนที่ และ -C (=O) Rx; n บ่งชี้ จำนวนเต็มที่ได้รับการคัดเลือกจาก 1 และ 2; และวงแหวน Ar ไดัรับการคัดเลือก จากหมู่ที่แทนโดยสูตร (a) ถึง (f) ต่อไปนี้ : [สูตร 2] (สูตรเคมี) (a) (สูตรเคมี) (b) (สูตรเคมี) (c) (สูตรเคมี) (d) (สูตรเคมี) (e) (สูตรเคมี) (f) หรือโพรดรักของสารประกอบ หรือเกลือที่สามารถยอมรับได้ทางเภสัชกรรมของ สารประกอบ และรวมทั้งยารักษาโรคและองค์ประกอบทางเภสัชกรรมที่มีสารประกอบ หรือ โพรดรัก ของสารประกอบ หรือเกลือที่สามารถยอมรับได้ทางเภสัชกรรมของสารประกอบ ดังกล่าว: Provided as a compound represented by formula (I) [Formula 1] (chemical formula (I), where R1, R2, R3, and R4 are independent of each other. Each group is selected from the hydrogen atom, the C1-6 alkyl group which may be substituted, the C7-14 aralkyl group which may be substituted, and -C (= O) Rx; n indicates the integer selected from 1 and 2; And the Ar ring has been selected From the group represented by the following formulas (a) to (f): [Formula 2] (Chemical Formula) (a) (Chemical Formula) (b) (Chemical Formula) (c) (Chemical Formula) (d) (Chemical Formula) (e. ) (Chemical formula) (f) or compound prop love Or pharmaceutical acceptable salts of compounds and including therapeutic agents and pharmaceutical constituents containing compounds or probiotics of the compound or of the pharmaceutical salts of such compounds:
Claims (1)
Publications (2)
Publication Number | Publication Date |
---|---|
TH104259A TH104259A (en) | 2010-09-24 |
TH104259B true TH104259B (en) | 2010-09-24 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1111999A1 (en) | Spiroketal derivative and use thereof as diabetic medicine | |
TW200745034A (en) | New compounds | |
EA200701176A1 (en) | NEW NAPHTHALINE COMPOUNDS, METHOD OF THEIR PRODUCTION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
WO2008081096A3 (en) | Quinolinyl derivatives, method for preparing same, pharmaceutic compositions containing same, and use thereof as hypoglycemiant and hypolipemiant agents | |
EA200600527A1 (en) | PPAR ACTIVATING COMPOUND AND CONTAINING ITS PHARMACEUTICAL COMPOSITION | |
PE20110845A1 (en) | NEW NITROGENATED HETEROCICLIC COMPOUNDS, PREPARATION OF THE SAME AND USE OF SAME AS ANTIBACTERIAL DRUGS | |
MX2009003927A (en) | Thioglucose spiroketal derivative and use thereof as therapeutic agent for diabetes. | |
HRP20070286T3 (en) | Substituted diketopiperazines and their use as oxytocyn antagonists | |
AR054508A1 (en) | BENCILPIPERAZINE COMPOSITE, ITS USE TO PREPARE A MEDICINAL PRODUCT, PROCEDURES FOR THE PREPARATION OF SUCH COMPOUND AND INTERMEDIATE COMPOUNDS, SUCH INTERMEDIARY COMPOUNDS, PHARMACEUTICAL COMPOSITION THAT INCLUDES IT AND PROCEDURE TO PREPARE IT | |
MY140325A (en) | Indanyl-piperazine derivatives, process for their preparation and pharmaceutical compositions containing them | |
UY29739A1 (en) | DERIVATIVES OF AMIDAS OR PHARMACEUTICALLY ACCEPTABLE SALTS OF THE SAME, PROCESSES OF PHARMACEUTICAL PREPARATIONS CONTAINING THEM AND APPLICATIONS | |
UY28688A1 (en) | AMIDA DERIVATIVES | |
TH104259B (en) | Spyrochetals with fused rings and their use As an antidiabetic drug | |
TH104259A (en) | Spyrochetals with fused rings and their use As an antidiabetic drug | |
UA90290C2 (en) | Spiroketal derivatives and use thereof as diabetic medicine | |
ATE522530T1 (en) | 2-PIPERAZINE-1-YL-3H-IMIDAZOÄ4,5-BÜ-PYRIDINE DERIVATIVES | |
TH98277B (en) | Heterocyclic acid compounds and their use | |
TH98277A (en) | Heterocyclic acid compounds and their use | |
TH60675A (en) | The use of pyridiodolone derivatives for the preparation of medicinal products | |
TH94332B (en) | Gamma Cystase inhibitor, ring-welded tricyclic sulfonamide group | |
TH94332A (en) | Gamma cystase inhibitor, ring-welded tricyclic sulfonamide group | |
TH106486A (en) | New types of 9-substrate-5-carboxy-oxadiazino-quinolone derivatives, their preparations and their use as antibacterial drugs. | |
TH83713B (en) | 2- (cyclic aminocarbonyl) derivatives and pharmaceutical ingredients containing this substance. | |
TH75088A (en) | Quinazolinone and benzosazinone derivatives and their use | |
TH86774B (en) | New type of hetero-aryl fusion cyclic amine |